Nitric oxide inhibits viral replication in murine myocarditis

Journal of Clinical Investigation

Volumn 97, Issue 8, 1996, Pages 1837-1843

  Lowenstein, Charles J ^a,c   Hill, Susan L ^a,b   Lafond Walker, Anne ^a   Wu, Jean ^a   Allen, Greg ^a,b   Landavere, Mike ^a,b   Rose, Noel R ^a,b   Herskowitz, Ahvie ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coxsackievirus; cytokines; enterovirus; inducible nitric oxide synthase; macrophage

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; COXSACKIE VIRUS B3; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; HOST RESISTANCE; IMMUNOREGULATION; INFECTION RESISTANCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS MYOCARDITIS; VIRUS REPLICATION;

EID: 0029996144     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118613     Document Type: Article

References (66)

1. Lowenstein, C.J., and S.H. Snyder, 1992. Nitric oxide, a novel biologic messenger. Cell. 70:705-707
2. Moncada, S., R.M. Palmer, and E A. Higgs. 1991. Nitric oxide, physiology, pathophysiology. and pharmacology. Pharmacol. Rev 43:109-142
3. Ignarro, L J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev. Pharmacol. Toxicol. 30:535-560.
4. Nathan, C., and Q.W. Xie 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
5. Marletta, M.A. 1994. Nitric oxide synthase: aspects concerning structure and catalysis Cell 78:926-930.
6. Stamler, J.S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936
7. Lowenstein, C.J., C S. Glatt, D.S. Bredt. and S.H. Snyder 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl Acad. Sci USA 89:6711-6715.
8. Xie, Q.W., H.J. Cho, J. Calaycay, R.A. Mumford, K.M Swiderek. T D. Lee, A. Ding. T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (Wash. DC) 256:225-228.
9. Lyons, C.R., G.J. Orloff, and J.M. Cunningham. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:6370-6374.
10. Lowenstein, C.J., E.W. Alley, P. Raval, A M. Snowman, S.H. Snyder, S.W. Russell, and W.J. Murphy. 1993. Macrophage nitric oxide synthase genetwo upstream regions mediate induction by Interferon gamma and lipopolysaccharide. Proc. Natl Acad. Sci USA. 90:9730-9734.
11. Xie, Q., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interfcron-γ and bacterial hpopolysaccharide. J. Exp Med. 177:1779-1784.
12. Croen, K.D. 1993. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest. 91-2446-2452.
13. Karupiah. G , Q.W Xie, R.M. Buller, C. Nathan. C. Duarte, and J D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (Wash. DC). 261:1445-1448.
14. Bi, Z., and C.S. Reiss. 1995 Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69 2208-2213.
15. Harris, N., R M. Buller, and G. Karupiah. 1995 Gamma interferoninduced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69 910-915.
16. Springer, T.A. 1981. Monoclonal antibody analysis of complex biological systems. J Biol. Chem. 256:3833-3839.
17. Springer, T.A., G. Galfre, D S. Secher, and C Milstein. 1978. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J. Immunol. 8-539-551
18. b bone marrow grafts. J. Exp. Med 170:191-202
19. Bredt, D.S , P.M. Hwang, and S.H. Snyder. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature (Lond.) 347. 768-770
20. Harlow, E., and D. Lane, 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor. NY. 53 pp.
21. Bredt, D.S., and S.H. Snyder 1990. Isolation of nitricoxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:682-685.
22. Wolfgram, L.J., K.W. Beisel, A. Herskowitz, and N.R. Rose. 1986. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Imnnunol. 136:1846-1852.
23. Herskowitz, A., L J. Wolfgram, N.R. Rose, and K.W Beisel. 1987 Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am. Coll Cardiol 9:1311-1319.
24. Lane, J.R., D.A. Neumann, A. Lafond Walker, A. Herskowitz. and N.R. Rose. 1992. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induccd myocarditis in resistant B10.A mice. J. Exp. Med. 175:1123-1129.
25. Lane, J.R., D.A Neumann, A. Lafond Walker, A. Herskowitz, and N.R. Rose. 1991. LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell, Immunol. 136:219-233.
26. Granger, D.L., J.B. Hibbs, Jr., and L.M Broadnax. 1991. Urinary nitrate excretion in relation to marine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine. J. Immunol. 146:1294-1302.
27. Kandolf, R., P. Kirschner. D. Ameis, A. Cairn, E. Erdman, H.P. Schultheiss, B. Kemkes, and P.H. Hofschneider. 1988. Enteroviral heart disease: diagnosis by in situ hybridization. In New Concepts in Viral Heart Disease, H.P. Schultheiss, editor. Springer-Verlag, Berlin. 337-348.
28. Dighiero, P., I. Reux, J.J. Hauw, A M Fillet, Y. Courtois, and O. Goureau 1994. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci. Lett. 166:31-34.
29. Mannick, J.B., K. Asano, K. Izumi, E. Kieff, and J.S. Stamler. 1995. Nitric oxide produced by human B lymphocytes inhibits apoptosis and EpsteinBarr virus reactivation. Cell 79 1137-1146.
30. Bukrinsky, M.I., H.S. Nottet. H. Schmidtmayerova, L. Dubrovsky, C.R. Fianagan, M.E. Mullins, S.A. Lipton, and H.E. Gendelman. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp. Med 181:735-745.
31. Lau, R.H., J.R. Jacob, J.H. Hotchkiss, P.J. Cote, J.L. Gerin, and B.C Tennant. 1994. Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. Carcinogenesis (Oxf.). 15:2875-2877
32. Lefer, A.M., P.S. Tsao, X.L. Ma, and T K. Sampath. 1992. Antiischaemic and endothehal protective actions of recombinant human osteogenic protein (hOP-1). J. Mol Cell Cardiol. 24:585-593.
33. Egdell, R.M., T. Siminiak, and DJ. Sheridan. 1994. Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion, Basic Res. Cardiol. 89:499-509
34. Niu, X.F., C.W. Smith, and P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1133-1140.
35. Ma, X.L . A.S. Weyrich. D.J. Lefer, and A.M. Lefer. 1993. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothehum. Circ. Res 72:403-412
36. Fortier, A.H., T. Polsinelli, S.J. Green, and C A Nacy. 1992. Activation of macrophages for destruction of Francisella rularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun. 60.817-825
37. Denis. M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 132:150-157.
38. Adams, L.B., S.G. Franzblau, Z. Vavrin, J.B Hibbs, Jr., and J.L. Krahenbuhl. 1991. L.-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobactenum leprae. J. Immunol. 147:1642-1646.
39. Beckerman, K.P., H W. Rogers, J.A. Corbett, R.D. Schreiber, M.L McDaniel, and E.R Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150 888-895.
40. MacMicking, J.D., C. Nathan, G. Horn, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.W Xie, K Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:641-650
41. Wei, X.Q., I.G. Charles, A Smith, J. Ure, C.J. Feng, F.F. Huang, D.M. Xu, W. Muller, S. Moncada, and F Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase Nature (Lond.). 375:408-411.
42. Henke, A , H.P. Spengler, A. Stelzner, M. Nain, and D Gemsa. 1992. Lipopolysaccharide suppresses cytokine release from coxsackie virus infected human monocytes. Res. Immunol, 143:65-70,
43. Lane, J.R., D.A. Neumann, A. Lafond-Walker, A. Herskowitz, and N R Rose. 1993. Role of IL-1 and tumor necrosis factor in coxsackie virusinduced autoimmune myocarditis. J. Immunol 151:1682-1686.
44. Henke, A., C. Mohr, H. Sprenger, C. Graebner, A. Stelzner, M. Nain, and D. Gemsa. 1992. Coxsackievirus B3 induced production of tumor necrosis factor-alpha, IL-1 beta, and IL-6 in human monocytes. J. Immunol. 148:2270-2277
45. Ungureanu-Longrois. D . J.L. Balligand. W.W. Simmons, I. Okada, L. Kobzik, C.J. Lowenstein, S.L. Kunkel. T. Michel. R.A, Kelly, and T W. Smith. 1995. induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists Circ. Res. 77:494-502
46. Balligand, J.L., D. Ungureanu-Longrois, W.W. Simmous, D, Pimental, T.A. Malinskt, M. Kapturczak, Z Taha, C.J. Lowenstein, A.J. Davidoff, and R.A. Kelly 1994 Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J. Biol Chem. 269:27580-27588
47. Pinsky, D.J., B Cai, X. Yang, C. Rodriguez, R.R. Sciacca, and P J. Cannon. 1995. The lethal effects of cytokine-mduced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin. Invest. 95:677-685.
48. Yang, X., N. Chowdhury, B. Cai, J. Brett, C. Marboe, R.R. Sciacca, R.E. Michler, and P.J. Cannon. 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J. Clin. Invest. 94:714-721.
49. Russell, M.E., A.F. Wallace, L.R. Wyner, J.B. Newell, and M.J. Karnovsky 1995. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation 92:457-464.
50. Worrall, N.K., W.D Lazenby, T.P. Misko, T.S. Lin, C.P. Rodi, P.T. Manning, R.G. Tilton, J.R. Williarason, and T.B. Ferguson. Jr. 1995. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181:63-70.
51. Kots. A.Y., A.V. Skurat, E.A. Sergienko, T.V. Bulargina, and E S. Severin. 1992. Nitroprusside stimulates the cysteine-specific mono (ADP-ribosylation) of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytcs. FEBS Lett. 300:9-12.
52. Zuang, J., and S.H. Snyder 1993. Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated beta-nicotinamide adenine dinucleotide. Biochemistry. 32:2228-2233.
53. Brune, B , and E.G. Lapetma. 1989. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem. 264:8455-8458.
54. Brune, B , and E.G. Lapetina. 1990. Properties of a novel nitric oxidestimulated ADP-ribosyltransferase. Arch. Biochem Biophys. 279:286-290.
55. Mateo, R.B., J.S. Reichner, B Mastrofrancesco, D. Kraft-Stolar. and J.E Albina 1995 Impact of nitric oxide on macrophage glucose metabolism and glyceraldehyde-3-phosphate dehydrogenase activity. Am. J. Phys. 268: C669-C675.
56. Welsh, N., D.L. Eizirik, K. Bendtzen, and S. Sandier. 1991. Interleukm-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology. 129:3167-3173.
57. Kilbourn. R.G., J. Klostergaard, and G. Lopez-Bernstem. 1984. Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. J. Immunol. 133:2577-2581.
58. Bolanos, J P., S. Peuchen, S.J. Heales, J.M Land, and J.B Clark. 1994 Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Nenrochem. 63:910-916.
59. Wink, D.A., K S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M Dunams, T A. Cebula, W.H Koch, A.W. Andrews, J.S. Allen, et al. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Wash. DC). 254:1001-1003
60. Nguyen T., D. Brunson, C.L. Crespi, B.W. Penman, J.S. Wishnok, and S.R. Tannenbaum. 1992. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci USA. 89:3030-3034.
61. Esumi, H., and S.R. Tannenbaum. 1994. U.S.-Japan Cooperative Cancer Research Program: seminar on nitric oxide synthase and carcinogenesis. Cancer Res. 54:297-301.
62. Lepoivre, M., F. Fieschi, J Coves, L Thelander, and M, Fontecave 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun 179.442-448.
63. Kwon, NS , D.J. Stuehr, and C.F. Nathan. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J. Exp Med 174: 761-768.
64. Rice, W G., C A. Schaeffer, B. Harten, F. Villinger, T.L. South, M.F. Summers, L.E. Henderson, J W. Bess, Jr., L O Arthur, J.S McDougal, et al. 1993. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature (Loun.). 361:473-475.
65. Godeny, E.K., and C.J Gauntt 1986. Involvement of natural killer cells in coxsackievirus B3 induced murine myocarditis. J Immunol 137:1670-1695.
66. Godeny, E.K., and C.J. Gauntt 1987 Murine natural killer cells limit coxsackievirus B3 replication. J. Immunol 139.913-920.